Although alcohol sometimes appears to be popular in the workplace, an expert warns the increasing trend could impact staff safety. Click here to view the interview...
TDDA media releases
Rise In Workplace Alcohol Detections
Since 2022, The Drug Detection Agency (TDDA) has seen alcohol detections rise significantly, with the detection rate nearly doubling during the 2022 and 2023 holiday periods. Traditionally, positive detections reduce after December and January, but initial testing...
The Drug Detection Agency Appoints New CEO.
8 May 2023, Auckland, New Zealand - The Drug Detection Agency (TDDA) is pleased to announce that Glenn Dobson has been appointed as the new CEO, effective from 1 May 2023. Dobson has an impressive career history throughout which he has demonstrated outstanding...
The Drug Detection Agency and Healthcare Holdings Enter Strategic Partnership
Healthcare Holdings Limited (HHL) takes stake in TDDA to augment health and wellbeing workplace offerings. The move enables TDDA to access assets, relationships, expertise, and capital through the partnership with HHL.
Hill Laboratories acquires laboratory drug analysis business from TDDA Omega Laboratories
Hill Laboratories, New Zealand’s largest privately owned analytical laboratory, has purchased the laboratory testing assets of TDDA Omega Laboratories. The sale encompasses all processes, technologies and equipment from TDDA Omega Laboratories.
Australia and New Zealand Receive Standardisation for Drug Oral Fluid Testing
The Drug Detection Agency (TDDA) welcomes the new standards for oral fluid testing processes and technologies. TDDA has long believed that oral fluid testing technology and processes required reviewing and to become a joint Australian and New Zealand standard.